MS-2223

A 42-year-old man has been released from the hospital after receiving a liver transplant. As a preventive measure against graft-versus-host disease, he has been prescribed an immunosuppressant that forms a complex with FK506 binding protein (FKBP) and inhibits calcineurin phosphatase. What is the name of the medication that this patient is likely taking?